Heat shock proteins 90-alpha (HSP90α) antibody and antigen (Recombinant protein)
Diagnostic Heat shock proteins 90-alpha (HSP90α) antibodies (anti-Heat shock proteins 90-alpha (HSP90α), anti-HSP90α) and antigens (recombinant Heat shock proteins 90-alpha (HSP90α) protein) for Cancer HSP90α detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-HSP90-Ag01 | Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein | 3090 |
GMP-h-HSP90-Ab01 | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-HSP90-Ab02 | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-HSP90-Ab03 | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) | 1953 |
GMP-h-HSP90-Ab04 | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-HSP90-Ag01 |
Product Name | Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein |
Target/Biomarker | Heat shock proteins 90-alpha (HSP90α) (HSP90α) |
Alias of Target/Biomarker | EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human HSP90AA1/HSP90α/HSP90A/HSPC1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-HSP90-Ab01, GMP-h-HSP90-Ab02 |
Product Name | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Heat shock proteins 90-alpha (HSP90α) (HSP90α) |
Alias of Target/Biomarker | EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-HSP90-Ab03, GMP-h-HSP90-Ab04 |
Product Name | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) |
Target/Biomarker | Heat shock proteins 90-alpha (HSP90α) (HSP90α) |
Alias of Target/Biomarker | EL52, HEL-S-65p, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp103, Hsp89, Hsp90, LAP-2, LAP2 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Heat shock proteins 90-alpha (HSP90α) (HSP90α) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HSP90α level test of Cancer (renal cancer, liver cancer and breast cancer) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human HSP90AA1/HSP90α/HSP90A/HSPC1 human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The Hsp90 family of heat shock proteins represents one of the most abundantly expressed and highly conserved families of cellular chaperones whose expression can be upregulated under conditions of cellular stress, and includes cytoplasmic (Hsp90-alpha/beta), ER (grp94), and mitochondrial (TRAP1) localized members. Structurally, Hsp90 is characterized by an N-terminal ATP-binding domain, a medial substrate-binding domain, and a C-terminal dimerization motif. Hsp90 dimers function in cooperation with cochaperones (e.g. Hsp40, Hsp70, Hop, p23) to stabilize a multitude of client protein substrates, including steroid hormone receptors, protein kinases, and transcription factors. The essential binding and hydrolysis of ATP by Hsp90 is inhibited by ansamycin drugs (e.g. geldanamycin, 17-AAG) which occupy the N-terminal Hsp90 nucleotide-binding pocket. Many Hsp90 client proteins such as erbB2/Her-2, c-raf, bcr-abl, p53, and hTERT, are members of well characterized oncogenic pathways, making Hsp90 inhibitors useful anticancer agents.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.